Comera Life Sciences Stock Price To Book
| CMRAWDelisted Stock | USD 0.04 0 5.07% |
Comera Life Sciences fundamentals help investors to digest information that contributes to Comera Life's financial success or failures. It also enables traders to predict the movement of Comera Stock. The fundamental analysis module provides a way to measure Comera Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Comera Life stock.
Comera |
Comera Life Sciences Company Price To Book Analysis
Comera Life's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
CompetitionBased on the latest financial disclosure, Comera Life Sciences has a Price To Book of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to book for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Comera Fundamentals
| Return On Equity | -16.29 | |||
| Return On Asset | -1.19 | |||
| Operating Margin | (15.82) % | |||
| Number Of Shares Shorted | 300 | |||
| Revenue | 1 M | |||
| EBITDA | (7.55 M) | |||
| Net Income | (9.01 M) | |||
| Cash And Equivalents | 3.86 M | |||
| Cash Per Share | 2.85 X | |||
| Total Debt | 775.05 K | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 4.26 X | |||
| Book Value Per Share | (12.62) X | |||
| Cash Flow From Operations | (6.66 M) | |||
| Earnings Per Share | (6.08) X | |||
| Number Of Employees | 12 | |||
| Beta | 0.41 | |||
| Total Asset | 3.73 M | |||
| Retained Earnings | (34.9 M) | |||
| Working Capital | (2 M) | |||
| Z Score | -20.17 | |||
| Net Asset | 3.73 M |
About Comera Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Comera Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Comera Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Comera Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Comera Stock
If you are still planning to invest in Comera Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Comera Life's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |